PubRank

R H Getzenberg

Author PubWeight™ 26.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Urine based markers of urological malignancy. J Urol 2001 1.61
2 Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J Urol 2000 1.15
3 Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 1994 1.13
4 Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin Cancer Res 2000 1.10
5 Nuclear structural proteins as biomarkers of cancer. J Cell Biochem 1999 1.08
6 Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res 1993 1.05
7 Cell structure and DNA organization. Crit Rev Eukaryot Gene Expr 1991 1.00
8 Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol 2001 0.98
9 The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. Mol Endocrinol 1998 0.98
10 Spinal cord compression in prostate cancer. J Neurooncol 1995 0.97
11 Association of transcription factors with the nuclear matrix. J Cell Biochem 1996 0.89
12 Workgroup 3: transgenic and reconstitution models of prostate cancer. Prostate 1998 0.89
13 NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells. J Cell Biol 1994 0.87
14 Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. J Natl Cancer Inst 1991 0.87
15 Association of vitamin D receptors with the nuclear matrix of human and rat genitourinary tissues. J Steroid Biochem Mol Biol 1998 0.84
16 Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J Urol 1998 0.81
17 Vitamin D in the prevention and treatment of prostate cancer. Semin Urol Oncol 1999 0.81
18 Effect of organ site on nuclear matrix protein composition. J Cell Biochem 1996 0.81
19 Use of urine-based markers for detection and monitoring of bladder cancer. Tech Urol 1999 0.80
20 Expression patterns of vitamin D receptor in human prostate. J Cell Biochem 2001 0.80
21 In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and prepubertal prostate. J Urol 2000 0.79
22 The role of vitamin D in normal prostate growth and differentiation. Cell Growth Differ 1996 0.79
23 Evaluation of the effect of spinal cord injury on serum PSA levels. Urology 2000 0.78
24 Nuclear matrix proteins as cancer markers. J Cell Biochem Suppl 2000 0.78
25 The effect of extracellular matrix interactions on morphologic transformation in vitro. Biochem Biophys Res Commun 1991 0.77
26 Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture. Urology 1999 0.77
27 Effect of prenatal vitamin D (calcitriol) exposure on the growth and development of the prostate. Prostate 1999 0.76
28 Characterization of nuclear morphology and nuclear matrices in ageing human fibroblasts. Mech Ageing Dev 1992 0.76
29 Update on urine-based markers for bladder cancer. How sensitive and specific are the new noninvasive tests? Postgrad Med 1999 0.76
30 Rat seminal-vesicle secretory protein SVS II binds DNA with a preference for the 5' regulatory region of secretory protein SVS IV gene: co-isolation with components of the nuclear matrix. J Androl 1999 0.75
31 The utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 1996 0.75
32 Novel therapies for advanced prostate cancer. Semin Urol Oncol 1997 0.75